Tbit™ Blood Testing Platform

Nano Technology

The breakthrough science integrated into the Tbit™ blood testing platform is based upon the revolutionary work of Charles Lieber, Professor of Chemistry, Harvard University and a pioneer of nanoscale technology. The unique design includes an array of ultrasensitive nanowires. BioDirection has developed a proprietary process that functionalizes the nanowires, allowing them to detect and measure specific protein molecules released by the brain immediately after a concussion. The unique size and electrical properties of the nanowires allow for single molecule capture never before available in a simple point-of-care device.

Nanowire sensors for medicine and the life sciences [pdf]
The interface between nanosystems and biosystems is emerging as one of the broadest and most dynamic areas of science and technology, bringing together biology, chemistry, physics and many areas of engineering, biotechnology and medicine...read more